RAB7A Protein

RAB7A Protein

Introduction

Rab7A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

RAB7A is a late endosomal small GTPase that coordinates cargo trafficking, autophagosome maturation, and lysosome fusion in [neurons](/entities/neurons).[@balderhaar2013][@nixon2013] It acts as a molecular switch cycling between GDP-bound inactive and GTP-bound active states, recruiting effectors that link membrane identity to motility and fusion machinery.[@balderhaar2013][@cantalupo2001] Because this node sits at the center of degradative trafficking, RAB7A dysfunction is mechanistically connected to both inherited neuropathy and age-related neurodegeneration.[@cogli2013][@saveri2020]

Protein Information

<div class="infobox infobox-protein">
| Property | Value |
|----------|-------|
| Protein Name | RAB7A (Ras-related protein Rab-7a) |
| Gene | [RAB7A](/genes/rab7a) |
| UniProt | [P51149](https://www.uniprot.org/uniprot/P51149) |
| PDB | [1YHN](https://www.rcsb.org/structure/1YHN), [1L0W](https://www.rcsb.org/structure/1L0W), [2FIP](https://www.rcsb.org/structure/2FIP) |
| Molecular Weight | ~23 kDa |
| Subcellular Localization | Late endosomes, lysosomes, autolysosome-associated membranes |
| Protein Family | Rab small GTPase family |
</div>

Core Molecular Functions

RAB7A has three tightly coupled roles:

RAB7A Protein

Introduction

Rab7A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

RAB7A is a late endosomal small GTPase that coordinates cargo trafficking, autophagosome maturation, and lysosome fusion in [neurons](/entities/neurons).[@balderhaar2013][@nixon2013] It acts as a molecular switch cycling between GDP-bound inactive and GTP-bound active states, recruiting effectors that link membrane identity to motility and fusion machinery.[@balderhaar2013][@cantalupo2001] Because this node sits at the center of degradative trafficking, RAB7A dysfunction is mechanistically connected to both inherited neuropathy and age-related neurodegeneration.[@cogli2013][@saveri2020]

Protein Information

<div class="infobox infobox-protein">
| Property | Value |
|----------|-------|
| Protein Name | RAB7A (Ras-related protein Rab-7a) |
| Gene | [RAB7A](/genes/rab7a) |
| UniProt | [P51149](https://www.uniprot.org/uniprot/P51149) |
| PDB | [1YHN](https://www.rcsb.org/structure/1YHN), [1L0W](https://www.rcsb.org/structure/1L0W), [2FIP](https://www.rcsb.org/structure/2FIP) |
| Molecular Weight | ~23 kDa |
| Subcellular Localization | Late endosomes, lysosomes, autolysosome-associated membranes |
| Protein Family | Rab small GTPase family |
</div>

Core Molecular Functions

RAB7A has three tightly coupled roles:

Through these processes, RAB7A function overlaps with [VPS41](/genes/vps41), [VPS18](/genes/vps18), and broader [autophagy-lysosomal dysfunction](/mechanisms/autophagy-lysosomal-dysfunction) mechanisms.

RAB7A in Neuronal Homeostasis

Neurons are especially sensitive to partial RAB7A dysfunction because trafficking defects accumulate over long distances and long lifespans. Even moderate fusion inefficiency can increase retention of damaged organelles and aggregation-prone proteins, amplify oxidative stress, and reduce synaptic maintenance capacity.[@nixon2013][@xu2021]

Recent work in neurons also highlights competitive control of RAB7-dependent fusion steps by different effectors, emphasizing that RAB7A signaling is dynamically tuned rather than constitutively on/off.[@xu2021] This context dependence helps explain how similar trafficking defects can produce distinct phenotypes across peripheral and central nervous system compartments.

Human Disease Associations

Charcot-Marie-Tooth Disease Type 2B (CMT2B)

Pathogenic missense variants in RAB7A cause autosomal dominant CMT2B, a predominantly axonal peripheral neuropathy often involving severe sensory loss and ulceromutilating complications.[@cogli2013][@saveri2020] Multiple functional studies show that mutant RAB7A proteins alter neurite biology, axonal growth/guidance, and intermediate filament interactions, supporting a direct trafficking-to-axon degeneration mechanism.[@cogli2013][@basuray2013][@mccray2016]

Broader Neurodegenerative Relevance

Although monogenic RAB7A disease is rare, pathway-level RAB7A impairment appears in diverse neurodegenerative contexts where autophagic flux is reduced. Experimental data link altered RAB7A activity to defective autophagosome-lysosome fusion, mitochondrial stress persistence, and increased proteotoxic vulnerability.[@nixon2013][@liang2023][@xiao2024]

This places RAB7A at a convergence point across [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and related disorders that involve endolysosomal stress and impaired degradative clearance.

Mechanistic Interface with HOPS and Trafficking Networks

RAB7A function is functionally coupled to HOPS-mediated tethering/fusion modules that include VPS41. Disruption of this interface impairs late-stage autophagic flux and biases cells toward cargo accumulation.[@balderhaar2013][@xu2021] In parallel, altered RAB7A-dependent transport can distort trophic signaling dynamics in axons, shifting neurons toward degeneration-prone states under chronic stress.[@basuray2013]

Because RAB7A is a nodal switch rather than a terminal enzyme, therapeutic modulation must preserve physiological trafficking while correcting pathological bias. Both insufficient and excessive Rab signaling can disrupt compartmental timing.

Therapeutic and Experimental Implications

Current translational interest in RAB7A focuses on restoring balanced trafficking rather than broad pathway over-activation:

In systems neuroscience, RAB7A remains a high-value perturbation target for testing whether improving terminal degradative fusion can shift disease trajectories in proteinopathy-driven disorders.[@nixon2013][@xu2021][@liang2023]

See Also

• [RAB7A Gene](/genes/rab7a)
• [VPS41 Gene](/genes/vps41)
• [Autophagy-Lysosomal Dysfunction Pathway](/mechanisms/autophagy-lysosomal-dysfunction-pathway)
• [Mitophagy](/mechanisms/mitophagy)
• [Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease)

Background

The study of Rab7A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Mitochondrial-Lysosomal Contact Site Engineering](/hypothesis/h-0791836f) — <span style="color:#ffd54f;font-weight:600">0.41</span> · Target: RAB7A